Skip to search.
 NZX 50 Down 0.48%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
4.57 Down 0.06(1.30%) 27 Aug 08:00
|After Hours : 4.57 Up 0.00 (0.02%) 27 Aug 09:02
Prev Close:4.63
Open:4.63
Bid:4.54 x 300
Ask:5.02 x 300
1y Target Est:7.14
Beta:2.97634
Earnings Date:27 Oct - 31 Oct (Est.)
Day's Range:4.53 - 4.80
52wk Range:2.80 - 7.80
Volume:1,270,980
Avg Vol (3m):1,680,190
Market Cap:483.94m
P/E (ttm):N/A
EPS (ttm):-1.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 1.30%483.94m
BAXUp 0.17%25.66b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.23
Quarterly EPS Est (Sep-16) :-0.21
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback